Center Organization and Infrastructure Unit

PS-OC组织了一个领导结构，以提供专门知识并充分支持所有举措。的 领导层由首席研究员Franziska Michor博士和高级合作研究员Eric Holland，MD，PhD.支助人员包括管理员/教育主任，沙漠马匹赠款， 研究/项目经理，Raquel Sanchez，MBA，生物统计学家，Mithat Gonen，PhD。PS-OC 领导和支持人员，也被称为管理，将共同努力，以支持和 完成拟议的研究项目、核心、教育和培训股、外联和传播 单位，试点和跨网络项目。PS-OC指导委员会（PSC）将每年举行一次会议， 由每个PS-OC的两名调查员组成。主要研究者Franziska Michor博士和 高级合作研究者Holland博士将代表我们的PS-OC参加PSC。 中心咨询委员会（CAC）将汇集具有物理和医学专业知识的研究人员， 科学和基础科学组成一个有表决权和无表决权的成员小组。具体来说，CAC 将由以下投票成员组成：两名物理科学成员，Franziska Michor（PD/PI）， 博士和Chris Sander博士;两名生物学/临床成员William Pao，MD/PhD和Eric Holland， MD/PhD;和NCI任命的投票成员。无表决权成员将包括至少两名外部成员。 具有广泛专业知识的顾问，一名外部顾问将在信号方面具有广泛的熟练程度 转导，癌症生物学，项目管理和关注与项目无关的肿瘤类型 的PS-OC。至少有一名其他外部顾问将对一项或多项 以下：进化理论，非进化癌症系统，发育生物学，脑癌，肺癌 癌症、白血病、应用数学或工程/微制造。

The PS-OC has organized a leadership structure to provide expertise and fully support all initiatives. The leadership consists of the Principal Investigator, Franziska Michor, PhD, and the Senior Co-investigator, Eric Holland, MD, PhD. Support personnel consists of the Administrator/Education Director, Desert Horse-Grant, Research/Project Manager, Raquel Sanchez, MBA, and Biostatistician, Mithat Gonen, PhD. The PS-OC leadership and support personnel, also known as the Administration, will work collectively to support and accomplish the proposed research projects, core, educational and training unit, outreach and dissemination unit, and pilot and trans-network projects. The PS-OC Steering Committee (PSC) will meet annually and will consist of two investigators from each PS-OC. The Principal Investigator, Dr. Franziska Michor, and the Senior Co-investigator, Dr. Holland, will represent our PS-OC at the PSC. The Center Advisory Committee (CAC) will bring together investigators with expertise in both the physical sciences and the basic sciences to form a group of voting and non-voting members. Specifically, the CAC will be made up of the following voting members: two physical sciences members, Franziska Michor (PD/PI), PhD, and Chris Sander, PhD; two biological/clinical members, William Pao, MD/PhD, and Eric Holland, MD/PhD; and an NCI appointed voting member. Non-voting members will include at least two external advisors with a wide spectrum of expertise, One external advisor will have a broad proficiency in signal transduction, cancer biology, program management and a focus on a tumor type unaffiliated with the projects of the PS-OC. At least one other external advisor will have advanced knowledge of one or more of the following: evolutionary theory, non-evolutionary cancer systems, developmental biology, brain cancer, lung cancer, leukemia, applied mathematics or engineering/microfabrication.